{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:22:45Z","timestamp":1792149765249,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.amjcard.2012.12.008","type":"journal-article","created":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T16:00:23Z","timestamp":1358524823000},"page":"923-929","source":"Crossref","is-referenced-by-count":16,"title":["Comparison of Change in Coronary Atherosclerosis in Patients With Stable Versus Unstable Angina Pectoris Receiving Statin Therapy (from the Treatment With Statin on Atheroma Regression Evaluated by Intravascular Ultrasound With Virtual Histology [TRUTH] Study)"],"prefix":"10.1016","volume":"111","author":[{"given":"Tsuyoshi","family":"Nozue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Tohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Umezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Kunishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Nozato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youichi","family":"Takeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Morino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Hibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyasu","family":"Terashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Michishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2012.12.008_bib1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial","volume":"291","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2012.12.008_bib2","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","article-title":"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial","volume":"295","author":"Nissen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2012.12.008_bib3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/01.CIR.0000140261.58966.A4","article-title":"Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study","volume":"110","author":"Okazaki","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.12.008_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jacc.2009.04.033","volume":"54","author":"Hiro","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.008_bib5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/0264-6021:3380479","article-title":"Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor","volume":"338","author":"MacPhee","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.amjcard.2012.12.008_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/01.ATV.0000191655.87296.ab","article-title":"Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans","volume":"26","author":"Yang","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2012.12.008_bib7","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM200010193431603","article-title":"Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease: West of Scotland Coronary Prevention Study Group","volume":"343","author":"Packard","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2012.12.008_bib8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.CIR.0000116763.91992.F1","article-title":"Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study","volume":"109","author":"Ballantyne","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.12.008_bib9","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jacc.2007.10.048","article-title":"Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study","volume":"51","author":"Daniels","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.008_bib10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.atherosclerosis.2011.09.019","article-title":"Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome","volume":"219","author":"Dohi","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2012.12.008_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ahj.2011.11.004","article-title":"Statin Treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis","volume":"163","author":"Nozue","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2012.12.008_bib12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1253\/circj.CJ-08-0593","article-title":"Treatment with statin on atheroma regression evaluated by intravascular ultrasound with virtual histology (TRUTH study): rationale and design","volume":"73","author":"Nozue","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.amjcard.2012.12.008_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4244\/EIJV5I2A29","article-title":"Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting","volume":"5","author":"Garc\u00eda-Garc\u00eda","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2012.12.008_bib14","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.4244\/EIJV6I9A195","article-title":"Clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound regression\/progression studies","volume":"6","author":"Mintz","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2012.12.008_bib15","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0735-1097(01)01175-5","volume":"37","author":"Mintz","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.008_bib16","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/01.ATV.19.5.1291","article-title":"Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids","volume":"19","author":"Leitinger","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2012.12.008_bib17","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1161\/01.ATV.17.10.2257","article-title":"Expression of phospholipase A2 isoforms in human normal and atherosclerotic arterial wall","volume":"17","author":"Elinder","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2012.12.008_bib18","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.amjcard.2005.01.023","article-title":"Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects","volume":"95","author":"Schaefer","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.008_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2005.05.006","article-title":"The effect of statin therapy on lipoprotein associated phospholipase A2 levels","volume":"182","author":"Albert","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2012.12.008_bib20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/hq0202.102918","article-title":"Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB","volume":"22","author":"Tsimihodimos","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2012.12.008_bib21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.amjcard.2009.04.012","article-title":"Relation between individual plaque components and overall plaque burden in the prospective, multicenter virtual histology intravascular ultrasound registry","volume":"104","author":"Qian","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.008_bib22","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.amjcard.2011.12.016","article-title":"Comparison of arterial remodeling and changes in plaque composition between patients with progression versus regression of coronary atherosclerosis during statin therapy (from the TRUTH study)","volume":"109","author":"Nozue","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.008_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1253\/circj.CJ-11-0730","article-title":"Virtual histology evaluation of atherosclerosis regression during atorvastatin and ezetimibe administration: HEAVEN study","volume":"76","author":"Kovarnik","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.amjcard.2012.12.008_bib24","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1253\/circj.CJ-12-0325","article-title":"Virtual histology findings and effects of varying doses of atorvastatin on coronary plaque volume and composition in statin-naive patients","volume":"76","author":"Lee","year":"2012","journal-title":"Circ J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912025507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912025507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T12:04:13Z","timestamp":1539950653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914912025507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0002914912025507"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2012.12.008","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}